Valproic Acid

PMID: 30000333

Abstract:

Valproic acid levels in breastmilk are low and infant serum levels range from undetectable to low. Breastfeeding during valproic acid monotherapy does not appear to adversely affect infant growth or development, and breastfed infants had higher IQs and enhanced verbal abilities than nonbreastfed infants at 6 years of age in one study.[1] If valproic acid is required by the mother, it is not necessarily a reason to discontinue breastfeeding.
No definite adverse reactions to valproic acid in breastfed infants have been reported. Theoretically, breastfed infants are at risk for valproic acid-induced hepatotoxicity, so infants should be monitored for jaundice and other signs of liver damage during maternal therapy. A questionable case of thrombocytopenia has been reported, so monitor the infant for unusual bruising or bleeding. One author recommends monitoring infant serum valproate levels, platelets and liver enzymes during therapy.[2] Combination therapy with sedating anticonvulsants or psychotropics may result in infant sedation or withdrawal reactions.

Chemicals Related in the Paper:

Catalog Number	Product Name	CAS Number	Price
AP1072951597	3,5-Diiodo-2-methoxyphenylboronic acid	1072951-59-7	Price
AP6929404	N-(+)-Biotinyl-4-aminobenzoic acid	6929-40-4	Price
AP849062164	3,5-Dimethyl-4-isopropoxyphenylboronic acid	849062-16-4	Price
AP870778964	2,4-Dibromo-6-fluorophenylboronic acid	870778-96-4	Price

As a specialist in analytical chemical Products, Alfa Chemistry offers consumers a wealth of raw materials and a full range of technologies and services.

QUICK LINKS

HEADQUARTERS

Tel:

Fax:

Email: